Xinshuang Yu
Overview
Explore the profile of Xinshuang Yu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
31
Citations
416
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wu W, Sui W, Chen S, Guo Z, Jing X, Wang X, et al.
Cell Metab
. 2025 Feb;
PMID: 39978336
Consumption of artificial sweeteners (ASWs) in various foods and beverages has been linked to an increased risk of cardiovascular diseases (CVDs). However, molecular mechanisms underlying ASW-associated CVD remain unknown. Here,...
2.
Liu B, Ye X, Fan W, Zhi X, Ma H, Wang J, et al.
J Cancer Res Ther
. 2024 Aug;
20(4):1109-1123.
PMID: 39206972
This expert consensus reviews current literature and provides clinical practice guidelines for the diagnosis and treatment of multiple ground glass nodule-like lung cancer. The main contents of this review include...
3.
Wu D, Yang L, Yan Y, Jiang Z, Liu Y, Dong P, et al.
Cancer Med
. 2024 May;
13(9):e7176.
PMID: 38716645
Background: In recent years, neoadjuvant immunotherapy (NAIT) has developed rapidly in patients with gastroesophageal junction cancer (GEJC). The suggested neoadjuvant treatment regimens for patients with GEJC may vary in light...
4.
Yan Y, Wu D, Wang W, Lv Y, Yang L, Liu Y, et al.
J Cancer Res Ther
. 2024 Apr;
20(2):633-641.
PMID: 38687934
Objective: To determine the effectiveness and safety of neoadjuvant therapy in gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs) and provide evidence-based suggestions for clinical treatment. Methods: The Cochrane Library, Embase, PubMed, and Web...
5.
Hou Y, Yang K, Wang L, Wang J, Huang X, Piffko A, et al.
Clin Cancer Res
. 2024 Mar;
30(9):1945-1958.
PMID: 38427437
Purpose: Radiotherapy (RT) is a widely employed anticancer treatment. Emerging evidence suggests that RT can elicit both tumor-inhibiting and tumor-promoting immune effects. The purpose of this study is to investigate...
6.
Dong P, Yan Y, Fan Y, Wang H, Wu D, Yang L, et al.
Technol Cancer Res Treat
. 2022 Dec;
21:15330338221142472.
PMID: 36573015
Pancreatic cancer has the highest mortality rate of all major cancers, with a 5-year survival rate of about 10%. Early warning signs and symptoms of pancreatic cancer are vague or...
7.
Dong P, Yan Y, Yang L, Wu D, Wang H, Lv Y, et al.
J Oncol
. 2022 Oct;
2022:2085267.
PMID: 36213828
Objective: Immunotherapy has shown better efficacy and less toxicity than chemotherapy in the treatment of non-small-cell lung cancer (NSCLC) at advanced stage. This study evaluates the safety and efficacy of...
8.
Chen Y, Wang Y, Ren F, Huang Z, Tan B, Zhao Z, et al.
Respir Res
. 2022 Oct;
23(1):274.
PMID: 36184624
Background: The recommendation of PCI for limited-stage small cell lung cancer (LS-SCLC) is primarily based on evidence from the pre-magnetic resonance imaging (MRI) era. However, as MRI accuracy improves and...
9.
Yin X, Tian M, Zhang J, Tang W, Feng L, Li Z, et al.
Cancer Lett
. 2022 May;
541:215746.
PMID: 35594995
Radiation therapy is effective in achieving local control in esophageal squamous cell carcinoma; however, changes in the tumor microenvironment induced by radiation can also promote metastasis. Dying tumor cells play...
10.
Zhang J, Yu Y, Yin X, Feng L, Li Z, Liu X, et al.
Front Genet
. 2022 May;
13:854097.
PMID: 35571014
Radiotherapy resistance is an important cause of treatment failure in esophageal squamous cell carcinoma (ESCC). Circular RNAs have attracted a lot of attention in cancer research, but their role in...